TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Initiation of TPT by 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TB diagnosis by 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trauma mortality
Endpoint domain: Mortality/survival
Primary endpoint: UACR improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Adherence to OAC at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom scores (frequency, severity and level of distress)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: initial hemostatic success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hemostasis time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean quality-of-life measures
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Serum testosterone decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: clinical impact of ticagrelor vs prasugrel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in heart rate reserve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: levels of enjoyment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensitivity for detection of large vessel occlusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Specificity for detection of large vessel occlusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Self-efficacy (SE) scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Net Benefit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDRS-R total score changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sustained opioid use (4-90 days postprocedure)
Endpoint domain: Adverse events/effects
Primary endpoint: Patient satisfaction with video consultations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Delirium Response Rate (DRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk for infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change in FVC (percent predicted)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in modified Rodnan skin score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No need of conversion to general anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: PMAL-how often
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PMAL-how well
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PDMS-2 visual motor integration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RGI‐C rickets total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total Rickets Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum alkaline phosphatase (ALP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24-month Villalta post-thrombotic syndrome (PTS) severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: venous disease-specific quality of life (QOL) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean pain scores at 5 days post-operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of painful alveolar osteitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of oral infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BBPS score 30 min after rectal washout
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric rating scale for pain 4 h after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaizey–Wexner score six weeks after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of WSLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LFV changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean average Hb levels at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Average change in Hb levels from baseline to week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cumulative response rate at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: motor outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum force in the midfoot and hallux
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: contact area in the midfoot, third metatarsal, and hallux
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak pressure in the hallux
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: counseling self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean 72-hour incontinence episodes frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Progression-free survival (PFS) quality-adjusted life-year (QALY) gained
Endpoint domain: Mortality/survival
Primary endpoint: Overall survival quality-adjusted life-year (QALY) gained
Endpoint domain: Mortality/survival
Primary endpoint: Decisional confidence score (DCS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of treated areas free of recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Feasibility of RIC treatment in NEC
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative complications incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Borg fatigue score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clotting time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cure rates at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA nadir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with PSA <0.4 ng/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRQOL in the irritative urinary domain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SteatoTest mean value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: ActiTest mean value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: TNF‐α inflammatory marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: anterior tongue strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: posterior tongue strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: salivary secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in knowledge regarding cervical cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disease-free survival rate at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Local control rate at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Learning outcome
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pain management scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual change of BMD at 1-year follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total change of BMD for three years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of correctly interpreting the test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to buy an HIV self-test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cumulative mortality within 90 days
Endpoint domain: Mortality/survival
Primary endpoint: disinhibition scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient IS use compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IS effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient engagement in their own care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: BSTAT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Airway anaesthesia scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of vasopressor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central venous pressure at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the ROC curve (AUC) for NAFLD Fibrosis Index (NFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absence of MBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood pixel count per frame
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Sexual health outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PR H-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced risk of subsequent stroke
Endpoint domain: Mortality/survival
Primary endpoint: Signs of atrophic vaginitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: CV death, nonfatal MI, or stroke
Endpoint domain: Mortality/survival
Primary endpoint: cumulated risk of internal herniation
Endpoint domain: Mortality/survival
Primary endpoint: Unhelpful cognitive biases regarding pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fahn‐Tolosa‐Marin Tremor Rating Scale total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Impression of Change (PGIC) assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: decisional conflict for germline testing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduction in cue-induced craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of TWOB task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse Events (grade ≥3)
Endpoint domain: Adverse events/effects
Primary endpoint: Median percent reductions in GTC seizures per 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Positive Predictive Value (PPV) for alcohol-related cirrhosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Positive Predictive Value (PPV) for cirrhosis with unspecified aetiology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Positive Predictive Value (PPV) for oesophageal varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Positive Predictive Value (PPV) for HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Positive Predictive Value (PPV) for liver-related ascites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: reduced school dropouts
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: increased motivation for school
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: economic independence and empowerment
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Confirmed acute ischemic infarct
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Acute Kidney Injury (AKI) occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of ICU admission
Endpoint domain: Resource use
Primary endpoint: Composite outcome of acute limb ischemia, major amputation for vascular causes, myocardial infarction, ischemic stroke, or death from cardiovascular causes
Endpoint domain: Mortality/survival
Primary endpoint: need for rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intraoperative cardiopulmonary variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: anastomotic stenosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Composite risk of hospital admission or death
Endpoint domain: Mortality/survival
Primary endpoint: IL-10 response enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pro-inflammatory mediators reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bacterial counts increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in PHQ-9 total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in SDS total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Skindex‐29 score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Leptin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: average pure tone hearing thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite outcome of stroke or thromboembolism, all-cause death, and rehospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Dizziness Handicap Inventory (DHI) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence in conducting AMD monitoring appointments
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy of detection of structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation in CCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal workload
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of postpartum hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Clinical competence of nursing staff
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction of doctors and patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean irregularity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum change in irregularity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of decrease in intra-abdominal pressure (IAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of symptoms of adhesive capsulitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPADI scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: CASI-5 composite score change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of OMT goals attained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LDL-C < 70 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Systolic blood pressure < 140 mm Hg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Functionally significant SB stenosis (FFR ≤ 0.80)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Gastrointestinal symptoms assessed using GDQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adverse events (AEs) during treatment
Endpoint domain: Adverse events/effects
Primary endpoint: serum peak ALT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: ICU and hospital stays
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Incidence of severe HFSR of grade II or higher
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: HF-QoL questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Funding support for harm reduction strategies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rates of recurrent VTE/VTE-related death
Endpoint domain: Mortality/survival
Primary endpoint: Barthel Index score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Chair-time management
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Weight-for-height z-score (WHZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diarrhoea leading to permanent treatment discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of HSV-2 infections
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of chlamydia infections
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of gonorrhea infections
Endpoint domain: Adverse events/effects
Primary endpoint: Combined counseling and NRT utilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day point prevalence abstinence at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ABP risk prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute physiology and chronic health evaluation II score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity of immune cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in serum E2 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in serum E1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: VMS frequency
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Feeling better on dialysis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical endpoint for treatment (probing depth ≥ 5 mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average GI values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Child's linear growth (HAZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delivery in a health facility
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Birth weights <2,500 g
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: 90-day functional independence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: swelling volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective change in tinnitus severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acetaminophen plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acetaminophen area under the concentration vs. time curve (AUC)0‐∞
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median terminal half‐life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart failure hospitalization risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain reporting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue reporting
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: V̇O2 peak (mL.kg‐1.min‐1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Development of MRONJ
Endpoint domain: Adverse events/effects
Primary endpoint: Patient-reported health state (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 400‐m walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plateau incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen consumption (ml min-1 W-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PASI improvement of 75% (PASI75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: PASI improvement of 90% (PASI90)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes